يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Gastric/gastroesophageal junction adenocarcinoma"', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

    المؤلفون: Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Cheng Xiao, Huan Wang, Lisong Teng, Hui Zhou, Shuyan Wang, Donglei Zhu, Bo Peng, Lin Shen, Nong Xu

    المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

    مصطلحات موضوعية: Sintilimab, Capecitabine, Oxaliplatin, Gastric/gastroesophageal junction adenocarcinoma, Tumor mutation burden, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: http://link.springer.com/article/10.1186/s12885-020-07251-z; https://doaj.org/toc/1471-2407

    URL الوصول: https://doaj.org/article/d2b3ceefa0024cee91685ee7edd4f9a7

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

    المؤلفون: Jiang, Haiping, Zheng, Yulong, Qian, Jiong, Mao, Chenyu, Xu, Xin, Li, Ning, Xiao, Cheng, Wang, Huan, Teng, Lisong, Zhou, Hui, Wang, Shuyan, Zhu, Donglei, Peng, Bo, Shen, Lin, Xu, NongAff1

    المصدر: BMC Cancer. 20(1)

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

    المؤلفون: Yulong Zheng, Xin Xu, Jiong Qian, Lin Shen, Haiping Jiang, Chenyu Mao, Bo Peng, Nong Xu, Shuyan Wang, Hui Zhou, Donglei Zhu, Cheng Xiao, Ning Li, Lisong Teng, Huan Wang

    المصدر: BMC Cancer
    BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

    مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Tumor mutation burden, Drug-Related Side Effects and Adverse Reactions, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Gastroenterology, lcsh:RC254-282, Severity of Illness Index, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, medicine, Humans, Adverse effect, Aged, business.industry, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Sintilimab, Progression-Free Survival, Oxaliplatin, Clinical trial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Gastric/gastroesophageal junction adenocarcinoma, Esophagogastric Junction, business, Progressive disease, medicine.drug, Research Article, Follow-Up Studies

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61b22b1650b3c7112aff8c90a061748
    http://europepmc.org/articles/PMC7427727

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء